Literature DB >> 20372938

Reduction of bone cancer pain by CB1 activation and TRPV1 inhibition.

Tomoyuki Kawamata1, Yukitoshi Niiyama, Jun Yamamoto, Shingo Furuse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20372938     DOI： 10.1007/s00540-010-0919-0

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  17 in total

1.  Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain.

Authors:  M J Schwei; P Honore; S D Rogers; J L Salak-Johnson; M P Finke; M L Ramnaraine; D R Clohisy; P W Mantyh
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord.

Authors:  V Morisset; L Urban
Journal:  J Neurophysiol       Date:  2001-07       Impact factor: 2.714

3.  Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.

Authors:  Christopher M Peters; Joseph R Ghilardi; Cathy P Keyser; Kazufumi Kubota; Theodore H Lindsay; Nancy M Luger; David B Mach; Matthew J Schwei; Molly A Sevcik; Patrick W Mantyh
Journal:  Exp Neurol       Date:  2005-05       Impact factor: 5.330

4.  The cloned capsaicin receptor integrates multiple pain-producing stimuli.

Authors:  M Tominaga; M J Caterina; A B Malmberg; T A Rosen; H Gilbert; K Skinner; B E Raumann; A I Basbaum; D Julius
Journal:  Neuron       Date:  1998-09       Impact factor: 17.173

5.  Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.

Authors:  Devi Rani Sagar; Sara Kelly; Paul J Millns; Celestine T O'Shaughnessey; David A Kendall; Victoria Chapman
Journal:  Eur J Neurosci       Date:  2005-07       Impact factor: 3.386

6.  Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo.

Authors:  S Kelly; V Chapman
Journal:  J Neurophysiol       Date:  2001-12       Impact factor: 2.714

7.  Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.

Authors:  E J Rahn; A Makriyannis; A G Hohmann
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

8.  Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain.

Authors:  J Yamamoto; T Kawamata; Y Niiyama; K Omote; A Namiki
Journal:  Neuroscience       Date:  2007-11-29       Impact factor: 3.590

9.  Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia.

Authors:  T Kawamata; W Ji; J Yamamoto; Y Niiyama; S Furuse; A Namiki
Journal:  Neuroscience       Date:  2008-04-12       Impact factor: 3.590

10.  Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.

Authors:  Nitin Agarwal; Pal Pacher; Irmgard Tegeder; Fumimasa Amaya; Cristina E Constantin; Gary J Brenner; Tiziana Rubino; Christoph W Michalski; Giovanni Marsicano; Krisztina Monory; Ken Mackie; Claudiu Marian; Sandor Batkai; Daniela Parolaro; Michael J Fischer; Peter Reeh; George Kunos; Michaela Kress; Beat Lutz; Clifford J Woolf; Rohini Kuner
Journal:  Nat Neurosci       Date:  2007-06-10       Impact factor: 24.884
View more
  8 in total

1.  Recent advances in pain medicine: from bench to bed; August 17, 2009, Kobe, Japan: Opening remarks.

Authors:  Toshiaki Minami; Soichiro Inoue
Journal:  J Anesth       Date:  2010-03-18       Impact factor: 2.078

2.  Depressive behavior in the forced swim test can be induced by TRPV1 receptor activity and is dependent on NMDA receptors.

Authors:  Ramy E Abdelhamid; Katalin J Kovács; Myra G Nunez; Alice A Larson
Journal:  Pharmacol Res       Date:  2013-11-04       Impact factor: 7.658

Review 3.  Skeletal lipidomics: regulation of bone metabolism by fatty acid amide family.

Authors:  Itai Bab; Reem Smoum; Heather Bradshaw; Raphael Mechoulam
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

4.  Resiniferatoxin (RTX) causes a uniquely protracted musculoskeletal hyperalgesia in mice by activation of TRPV1 receptors.

Authors:  Ramy E Abdelhamid; Katalin J Kovács; Christopher N Honda; Myra G Nunez; Alice A Larson
Journal:  J Pain       Date:  2013-11-01       Impact factor: 5.820

5.  Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.

Authors:  Devki Sukhtankar; Alec Okun; Anupama Chandramouli; Mark A Nelson; Todd W Vanderah; Anne E Cress; Frank Porreca; Tamara King
Journal:  Mol Pain       Date:  2011-10-20       Impact factor: 3.395

6.  Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells.

Authors:  Ahmad Mohammadi-Farani; Mahmoud Ghazi-Khansari; Mousa Sahebgharani
Journal:  Iran J Basic Med Sci       Date:  2014-09       Impact factor: 2.699

Review 7.  Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review.

Authors:  Yuqi Xin; Anqun Tang; Shuting Pan; Jie Zhang
Journal:  Front Pharmacol       Date:  2022-01-19       Impact factor: 5.810

8.  Centipede Venom Peptides Acting on Ion Channels.

Authors:  YanYan Chu; PeiJu Qiu; RiLei Yu
Journal:  Toxins (Basel)       Date:  2020-04-05       Impact factor: 4.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.